Sign In
Buy GXGX
$7.38
+0 (+0%)
At Close: Aug 17, 2022
Why GX Acquisition Stock Soared Today
04:09pm, Friday, 16'th Jul 2021
The SPAC closed its merger with clinical-stage biotech Celularity.
GXGX Merger: The SPAC News That Has GXGX Stock Soaring
02:39pm, Friday, 16'th Jul 2021
GXGX's merger announcement is causing the stock to soar this afternoon. The SPAC is merging with biotech play Celularity.
GX Acquisition Corp. Announces Shareholder Approval of Extension Proposal
04:45pm, Friday, 14'th May 2021
NEW YORK, May 14, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, announced today that its stockholders have voted to approve a
GX Acquisition Corp. Announces Additional Contributions to Trust Account
07:30am, Monday, 10'th May 2021
NEW YORK, May 10, 2021 /PRNewswire/ -- GX Acquisition Corp. ("GX") (NASDAQ: GXGX), a publicly-traded special purpose acquisition company, today reaffirmed its intention to support the proposal to a
7 Upcoming SPAC Mergers to Avoid
01:14pm, Wednesday, 03'rd Mar 2021
The stock market has suddenly broken to the downside over the past two weeks. That makes these SPACs particularly risky bets as the momentum fades.
Global Nutrigenomics Market- Featuring BASF SE, Cell-Logic, Danone, DSM, and Genova Diagnostics Inc. Among Others | Technavio
12:00am, Wednesday, 16'th Sep 2020
The Global Nutrigenomics Market will grow by USD 425.61 mn during 2020-2024
